Skip to content
Home/Companies/Biotech/Genepep

Genepep

Biotech·Switzerland·Exited 2016·Held 9yr
Entry
2007
Hold
9yr
Exit
2016

Who owns Genepep?

Genepep is a Swiss Biotech company, formerly owned by Naxicap Partners, exited in 2016 (exit via MBO). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Naxicap Partners
Investor
Naxicap Partners
Naxicap Legacy Funds · 2005 · Buyout

Key facts

HQSwitzerland
SectorBiotech
Exit Type
MBO
Buyer
TWO-C
Exit Year
2016

More from Naxicap Legacy Funds

Other portfolio companies in the same fund.

BIA
Active
ConsumerFrance
SUD Robinetterie Industrie (SRI)
Active
Business ServicesFrance
WEBINFLUENCE GROUP / ADCASH
Webinfluence Group / Adcash
Active
AdTechFrance
ALTARES
Altares
Active
Business ServicesFrance· 2016
DCI
Exited 2023
IT ServicesFrance· 2016
Genoyer International
Active
Business ServicesFrance· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Genepep?

Genepep was formerly owned by Naxicap Partners, exited in 2016. No current private equity owner is on file.

Who did Genepep sell to?

Naxicap Partners sold Genepep to TWO-C in 2016 (MBO).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue